• Careers
  • Contact
Synthekine
  • About Us
    • Our Story
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Our Partners
  • Our Platforms
    • About Cytokines
    • Protein Engineering Platforms
    • Posters and Publications
  • Our Pipeline
    • Our Pipeline
    • STK-012
    • STK-009 + SYNCAR-001
    • Additional Programs
  • News
    • Press Releases
  • Twitter
  • Linked In
  • Menu Menu
  • About Us
    • Our Story
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Our Partners
  • Our Platforms
    • About Cytokines
    • Protein Engineering Platforms
    • Posters and Publications
  • Our Pipeline
    • Pipeline
    • STK-012
    • STK-009 + SYNCAR-001
    • Additional Programs
  • News
    • Press Releases
  • Careers
  • Contact
  • Twitter
  • Linked In

Synthekine Secures $100 Million Series C Financing to Advance Pipeline of Engineered Cytokine Therapeutics

January 5, 2023/in 2023, news/by Emily Hennes

January 6, 2023

Read more
/wp-content/uploads/logo-300x63.png 0 0 Emily Hennes /wp-content/uploads/logo-300x63.png Emily Hennes2023-01-05 17:26:342023-01-05 19:12:40Synthekine Secures $100 Million Series C Financing to Advance Pipeline of Engineered Cytokine Therapeutics
  • About Us
    • Our Story
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Our Partners
  • Our Platforms
    • About Cytokines
    • Protein Engineering Platforms
    • Posters and Publications
  • Our Pipeline
    • Our Pipeline
    • STK-012
    • STK-009 + SYNCAR-001
    • Additional Programs
  • News
    • Press Releases
  • Twitter
  • Linked In
  • Careers
  • Contact

Copyright 2023 – Synthekine

Scroll to top